Osprey Medical gets FDA OK for angiogram device

08/26/2013 | BioSpectrum Asia

Osprey Medical has been cleared by the FDA to market its Avert System, which is used to minimize patient exposure to dye during angiogram or diagnostic heart procedures. A clinical study showed the device was able to lower by as much as 40% the amount of dye used during angiograms while maintaining image quality.

View Full Article in:

BioSpectrum Asia

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA